Pragmatic clinical trial design in emergency medicine: Study considerations and design types

Pragmatic clinical trials (PCTs) focus on correlation between treatment and outcomes in real‐world clinical practice, yet a guide highlighting key study considerations and design types for emergency medicine investigators pursuing this important study type is not available. Investigators conducting...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Academic emergency medicine 2022-10, Vol.29 (10), p.1247-1257
Hauptverfasser: Gettel, Cameron J., Yiadom, Maame Yaa A. B., Bernstein, Steven L., Grudzen, Corita R., Nath, Bidisha, Li, Fan, Hwang, Ula, Hess, Erik P., Melnick, Edward R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Pragmatic clinical trials (PCTs) focus on correlation between treatment and outcomes in real‐world clinical practice, yet a guide highlighting key study considerations and design types for emergency medicine investigators pursuing this important study type is not available. Investigators conducting emergency department (ED)‐based PCTs face multiple decisions within the planning phase to ensure robust and meaningful study findings. The PRagmatic Explanatory Continuum Indicator Summary 2 (PRECIS‐2) tool allows trialists to consider both pragmatic and explanatory components across nine domains, shaping the trial design to the purpose intended by the investigators. Aside from the PRECIS‐2 tool domains, ED‐based investigators conducting PCTs should also consider randomization techniques, human subjects concerns, and integration of trial components within the electronic health record. The authors additionally highlight the advantages, disadvantages, and rationale for the use of four common randomized study design types to be considered in PCTs: parallel, crossover, factorial, and stepped‐wedge. With increasing emphasis on the conduct of PCTs, emergency medicine investigators will benefit from a rigorous approach to clinical trial design.
ISSN:1069-6563
1553-2712
1553-2712
DOI:10.1111/acem.14513